Spanish Red Biotech Pipeline

Leukos Biotech

LB208

Type: Biodrugs/ Drugs
Therapeutic area:
Indication: Specific and selective HTR1B antagonist, providing a antitumoral agent with potential to address current unmet needs in solid tumors such as TNBC, Hepatocellular Carcinoma or Ovarian Cancer, and in hematological malignancies such as AML or MDS.
Phase: 2Regulatory Preclinical, 1Non Regulatory Preclinical